| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.2 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.084 | 0.2 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |